Citation: Jun-Hang Jiang, Can-Hui Zheng, Chong-Qing Wang, Juan Wang, Wei Tian, Chao Yang, Yun-Long Song, Yong Hu, Ju Zhu, You-Yun Zhou. Synthesis and biological evaluation of 5,6,7-trimethoxy- 1- benzylidene-3,4-dihydro-naphthalen-2-one as tubulinpolymerization inhibitors[J]. Chinese Chemical Letters, ;2015, 26(5): 607-609. doi: 10.1016/j.cclet.2015.03.022 shu

Synthesis and biological evaluation of 5,6,7-trimethoxy- 1- benzylidene-3,4-dihydro-naphthalen-2-one as tubulinpolymerization inhibitors

Jun-Hang Jiang ^a ,
Can-Hui Zheng ^a ,
Chong-Qing Wang ^a ,
Juan Wang ^c ,
Wei Tian ^a ,
Chao Yang ^a ,
Yun-Long Song ^a ,
Yong Hu ^b,, ,
Ju Zhu ^a,, ,
You-Yun Zhou ^a,,

1.
a School of Pharmacy, Second Military Medical University, Shanghai 200433, China;
2.
b Department of Neonatology, Shanghai Children’s Hospital, Shanghai Jiao Tong University, Shanghai 200040, China;
3.
c Shanghai Institute of Pharmaceutical Industry, Shanghai 200437, China

Corresponding author: Yong Hu, Ju Zhu, You-Yun Zhou,
Received Date: 18 January 2015
Available Online: 28 February 2015
Fund Project: "Chen Guang" Project supported by Shanghai Municipal Education Commission and Shanghai Education Development Foundation (No. 12CG42). (No. 09ZR1438800)

A series of new combretastatin-A4 analogs were synthesized, in which a six-membered ring connects the linking bridge and A ring, and their tumor cell growth and tubulin-polymerization inhibitory activity were evaluated. These compounds appear to be potential tubulin-polymerization inhibitors. Compounds 1b with amino substituted on position 3 of B ring conferred optimal bioactivity, higher than that of the lead compound 22b and equivalent to that of CA-4. The binding modes of these compounds to tubulin were obtained by molecular docking, which can explain the structure-activity relationship. The studies presented here provide a new structural type for the development of novel antitumor agents.
- Tubulin polymerization inhibitor,
- Antitumor agent,
- Combretastatin-A4 analog
1. [1]
  [1] M.A. Jordan, L. Wilson, Microtubules as a target for anticancer drugs, Nat. Rev. Cancer 4 (2004) 253-265.
2. [2]
  [2] C. Dumontet, M.A. Jordan, Microtubule-binding agents: a dynamic field of cancer therapeutics, Nat. Rev. Drug Discov. 9 (2010) 790-803.
3. [3]
  [3] N.H. Nam, Combretastatin A-4 analogues as antimitotic antitumor agents, Curr. Med. Chem. 10 (2003) 1697-1722.
4. [4]
  [4] L.H. Shen, H.Y. Li, H.X. Shang, et al., Synthesis and cytotoxic evaluation of new colchicine derivatives bearing 1,3,4-thiadiazole moieties, Chin. Chem. Lett. 24 (2013) 299-302.
5. [5]
  [5] T. Ai, S.Y. Shi, L.T. Chen, et al., Synthesis and anti-tumor activity evaluation of novel podophyllotoxin derivatives, Chin. Chem. Lett. 24 (2013) 37-40.
6. [6]
  [6] G.C. Tron, T. Pirali, G. Sorba, et al., Medicinal chemistry of combretastatin A4: present and future directions, J. Med. Chem. 49 (2006) 3033-3044.
7. [7]
  [7] Y.S. Shan, J. Zhang, Z. Liu, M. Wang, Y. Dong, Developments of combretastatin A-4 derivatives as anticancer agents, Curr. Med. Chem. 18 (2011) 523-538.
8. [8]
  [8] D.W. Siemann, D.J. Chaplin, P.A. Walicke, A review and update of the current status of the vasculature-disabling agent combretastatin-A4 phosphate (CA4P), Expert Opin. Invest. Drugs 18 (2009) 189-197.
9. [9]
  [9] S. Zheng, Q. Zhong, M. Mottamal, et al., Design, synthesis, and biological evaluation of novel pyridine-bridged analogues of combretastatin-A4 as anticancer agents, J. Med. Chem. 57 (2014) 3369-3381.
10. [10]
  [10] R. Romagnoli, P.G. Baraldi, C. Lopez-Cara, et al., Concise synthesis and biological evaluation of 2-aroyl-5-amino benzo [b] thiophene derivatives as a novel class of potent antimitotic agents, J. Med. Chem. 56 (2013) 9296-9309.
11. [11]
  [11] R. Álvarez, P. Puebla, J.F. Díaz, et al., Endowing indole-based tubulin inhibitors with an anchor for derivatization: highly potent 3-substituted indolephenstatins and indoleisocombretastatins, J. Med. Chem. 56 (2013) 2813-2827.
12. [12]
  [12] H.Y. Lee, J.Y. Chang, C.Y. Nien, et al., 5-Amino-2-aroylquinolines as highly potent tubulin polymerization inhibitors. Part 2. The impact of bridging groups at position C-2, J. Med. Chem. 54 (2011) 8517-8525.
13. [13]
  [13] C.H. Zheng, J. Chen, J. Liu, et al., Synthesis and biological evaluation of 1-phenyl- 1,2,3,4-dihydroisoquinoline compounds as tubulin polymerization inhibitors, Arch. Pharm. 345 (2012) 454-462.
14. [14]
  [14] Y.W. Li, J. Liu, N. Liu, et al., Imidazolone-amide bridges and their effects on tubulin polymerization in cis-locked vinylogous combretastatin-A4 analogues: synthesis and biological evaluation, Bioorg. Med. Chem. 19 (2011) 3579-3584.
15. [15]
  [15] A. Andreani, S. Burnelli, M. Granaiola, et al., Antitumor activity of substituted E- 3-(3,4,5-trimethoxybenzylidene)-1,3-dihydroindol-2-ones 1, J. Med. Chem. 49 (2006) 6922-6924.
16. [16]
  [16] J.P. Liou, Y.L. Chang, F.M. Kuo, et al., Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents, J. Med. Chem. 47 (2004) 4247-4257.
17. [17]
  [17] X. Ren, M. Dai, L.P. Lin, et al., Anti-angiogenic and vascular disrupting effects of C9, a new microtubule-depolymerizing agent, Br. J. Pharmacol. 156 (2009) 1228-1238.
18. [18]
  [18] J. Liu, C.H. Zheng, X.H. Ren, et al., Synthesis and biological evaluation of 1-benzylidene- 3,4-dihydronaphthalen-2-one as a new class of microtubule-targeting agents, J. Med. Chem. 55 (2012) 5720-5733.
19. [19]
  [19] GOLD 5.0., Cambridge Crystallographic Data Centre, Cambridge, UK, 2011.
20. [20]
  [20] Discovery Studio 3.0, Accelrys, Inc., San Diego, CA, 2013.
1. [1]
  Fengqing Wang , Changxing Qi , Chunmei Chen , Qin Li , Qingyi Tong , Weiguang Sun , Zhengxi Hu , Minyan Wang , Hucheng Zhu , Lianghu Gu , Yonghui Zhang . Discovery and enantioselective total synthesis of antitumor agent asperfilasin A via a regio- and diastereoselective Nazarov cyclization. Chinese Chemical Letters, 2025, 36(6): 110252-. doi: 10.1016/j.cclet.2024.110252
2. [2]
  Jian Song , Shenghui Wang , Qiuge Liu , Xiao Wang , Shuo Yuan , Hongmin Liu , Saiyang Zhang . N-Benzyl arylamide derivatives as novel and potent tubulin polymerization inhibitors against gastric cancers: Design, structure–activity relationships and biological evaluations. Chinese Chemical Letters, 2025, 36(2): 109678-. doi: 10.1016/j.cclet.2024.109678
3. [3]
  Hong-Tao Ji , Yu-Han Lu , Yan-Ting Liu , Yu-Lin Huang , Jiang-Feng Tian , Feng Liu , Yan-Yan Zeng , Hai-Yan Yang , Yong-Hong Zhang , Wei-Min He . Nd@C₃N₄-photoredox/chlorine dual catalyzed synthesis and evaluation of antitumor activities of 4-alkylated sulfonyl ketimines. Chinese Chemical Letters, 2025, 36(2): 110568-. doi: 10.1016/j.cclet.2024.110568
4. [4]
  Zhexin Chen , Yuqing Shi , Fang Zhong , Kai Zhang , Furong Zhang , Shenghong Xie , Zhongbin Cheng , Qian Zhou , Yi-You Huang , Hai-Bin Luo . Discovery of amentoflavone as a natural PDE4 inhibitor with anti-fibrotic effects. Chinese Chemical Letters, 2025, 36(4): 109956-. doi: 10.1016/j.cclet.2024.109956
5. [5]
  Qiong-Hui Peng , Ning-Bo Li , Jia-Cheng Hou , Cai-Jun He , Ya-Xin Yang , Chun-Lin Zhuang , Li-Juan Ou , Mei Yuan , Wei-Min He . Nd@g-C₃N₄ dual-functional photosynthesis and antitumor activities of 3-fluoroalkylated quinoxalin-2(1H)-ones. Chinese Chemical Letters, 2025, 36(12): 111402-. doi: 10.1016/j.cclet.2025.111402
6. [6]
  Tao LIU , Yuting TIAN , Ke GAO , Xuwei HAN , Ru'nan MIN , Wenjing ZHAO , Xueyi SUN , Caixia YIN . A photothermal agent with high photothermal conversion efficiency and high stability for tumor therapy. Chinese Journal of Inorganic Chemistry, 2024, 40(8): 1622-1632. doi: 10.11862/CJIC.20240107
7. [7]
  Ying Zhang , Chuang Shen , Jiaxu Zhang , Qi Shen , Fei Xu , Shengheng Wang , Jiuyi Hu , Faisal Saleem , Feng Huang , Zhimin Luo . Ultrasmall PtCu nanosheets as a broadband phototheranostic agent in near-infrared biowindow. Chinese Chemical Letters, 2025, 36(6): 111059-. doi: 10.1016/j.cclet.2025.111059
8. [8]
  Zhi-Lin Wu , Rong-Nan Yi , Chunlin Zhuang . Electrochemical synthesis strategy for the development of antitumor selenoheterocyclic compounds. Chinese Chemical Letters, 2025, 36(10): 111408-. doi: 10.1016/j.cclet.2025.111408
9. [9]
  Jing Zhang , Charles Wang , Yaoyao Zhang , Haining Xia , Yujuan Wang , Kun Ma , Junfeng Wang . Application of magnetotactic bacteria as engineering microrobots: Higher delivery efficiency of antitumor medicine. Chinese Chemical Letters, 2024, 35(10): 109420-. doi: 10.1016/j.cclet.2023.109420
10. [10]
  Di ZHANG , Tianxiang XIE , Xu HE , Wanyu WEI , Qi FAN , Jie QIAO , Gang JIN , Ningbo LI . Construction and antitumor activity of pH/GSH dual-responsive magnetic nanodrug. Chinese Journal of Inorganic Chemistry, 2025, 41(4): 786-796. doi: 10.11862/CJIC.20240329
11. [11]
  Qian Chen , Anyang Shen , Taotao Huang , Xinya Han , Jian Zhang , Hui Jiang , Renyong Liu , Yong Pan , Kui Zhang . Ultrasensitive and selective detection of chemical nerve agent simulants based on naphthalimide functionalized chitosan as fluorescent nanofibers. Chinese Chemical Letters, 2025, 36(7): 110331-. doi: 10.1016/j.cclet.2024.110331
12. [12]
  Yanyan Ma , Lizhen Xu , Muxin Xu , Jie Niu , Wei Xu , Weiying Lin . All in one: An in-situ activated tumor theranostic agent for NIR-Ⅱ fluorescence imaging guided surgical resection and photothermal therapy. Chinese Chemical Letters, 2025, 36(11): 110850-. doi: 10.1016/j.cclet.2025.110850
13. [13]
  Jin Wang , Xiaoyan Pan , Junyu Zhang , Qingqing Zhang , Yanchen Li , Weiwei Guo , Jie Zhang . Active molecule-based theranostic agents for tumor vasculature normalization and antitumor efficacy. Chinese Chemical Letters, 2024, 35(8): 109187-. doi: 10.1016/j.cclet.2023.109187
14. [14]
  Zhaomin Tang , Qian He , Jianren Zhou , Shuang Yan , Li Jiang , Yudong Wang , Chenxing Yao , Huangzhao Wei , Keda Yang , Jiajia Wang . Active-transporting of charge-reversal Cu(Ⅱ)-doped mesoporous silica nanoagents for antitumor chemo/chemodynamic therapy. Chinese Chemical Letters, 2024, 35(7): 109742-. doi: 10.1016/j.cclet.2024.109742
15. [15]
  Hu Wu , Ge Cao , Mingyang Liu , Hainan Xu , Meng Li , Hanwei Huang , Yujie Liu , Xu Zhao , Xifeng Qin , Onder Ergonul , Füsun Can , Funan Liu , Zhiqing Pang , Jiaming Zhu . Tumor cell membrane biomimetic liposomes-coated oncolytic viruses to target the homotypic tumor and augment the antitumor efficacy. Chinese Chemical Letters, 2025, 36(7): 110493-. doi: 10.1016/j.cclet.2024.110493
16. [16]
  Yongjuan Li , Rongrong Zhu , Yichen Guo , Yayun Wang , Rong Ma , Kunru Ma , Yongxing Zhao , Weijing Yang . Sequential-gated transformable nanoprodrug potentiates antitumor immunity through TME modulation and STING activation. Chinese Chemical Letters, 2025, 36(9): 110704-. doi: 10.1016/j.cclet.2024.110704
17. [17]
  Yixin Sun , Keke Yu , Xiuchun Guo , Lanlan Zong , Zhonggui He , Xiaohui Pu . Three-in-one reduction and acid-ignited micelles amplify antitumor efficacy via precise synergistic delivery of paclitaxel and naringenin. Chinese Chemical Letters, 2025, 36(6): 110393-. doi: 10.1016/j.cclet.2024.110393
18. [18]
  Hailong He , Wenbing Wang , Wenmin Pang , Chen Zou , Dan Peng . Double stimulus-responsive palladium catalysts for ethylene polymerization and copolymerization. Chinese Chemical Letters, 2024, 35(7): 109534-. doi: 10.1016/j.cclet.2024.109534
19. [19]
  Yiran Tao , Chunlei Dai , Zhaoxiang Xie , Xinru You , Kaiwen Li , Jun Wu , Hai Huang . Redox responsive polymeric nanoparticles enhance the efficacy of cyclin dependent kinase 7 inhibitor for enhanced treatment of prostate cancer. Chinese Chemical Letters, 2024, 35(8): 109170-. doi: 10.1016/j.cclet.2023.109170
20. [20]
  Jia Chen , Yun Liu , Zerong Long , Yan Li , Hongdeng Qiu . Colorimetric detection of α-glucosidase activity using Ni-CeO₂ nanorods and its application to potential natural inhibitor screening. Chinese Chemical Letters, 2024, 35(9): 109463-. doi: 10.1016/j.cclet.2023.109463

Get Citation

PDF

XML

Metrics

PDF Downloads(0)
Abstract views(1074)
HTML views(7)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142